Gercor - Multidisciplinary Oncology Cooperative Group
Clinical trials sponsored by Gercor - Multidisciplinary Oncology Cooperative Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can acupuncture soothe Chemotherapy's lingering nerve pain? Results expected Oct 2026 (estimated)
- Gut bacteria pill could boost stomach cancer treatment Results expected Sep 2027 (estimated)
-
Immunotherapy may let some cancer patients skip the knife
Cure Recruiting nowThis phase II trial is testing whether the immunotherapy drug dostarlimab can eliminate the need for surgery in people with a specific type of stomach or gastroesophageal junction cancer that has a genetic marker called dMMR/MSI-H. Participants receive dostarlimab infusions, and …
Phase 2 • Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Cure
Last updated Aug 28, 2026 00:00 UTC
-
Gut bacteria pill could boost stomach cancer treatment
Disease control Recruiting nowThis phase 2 trial tests whether adding a daily pill containing a specific gut bacterium (EXL01) to standard immunotherapy (nivolumab) and chemotherapy (FOLFOX) can shrink tumors better than the drugs alone in people with advanced gastric cancer. About 120 participants will be ra…
Phase 2 • Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a Pre-Surgery boost help cancer patients recover faster?
Symptom relief Recruiting nowThis study tests an 8-week program of nutrition advice, exercise, and psychological support for people with pancreatic or esophageal cancer before they have surgery. The goal is to see if patients can complete the program and if it helps them prepare for surgery. Only 9 patients …
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can acupuncture soothe Chemotherapy's lingering nerve pain?
Symptom relief Recruiting nowThis phase II trial tests whether a standardized acupuncture protocol can reduce peripheral neuropathy, a common and often lasting side effect of oxaliplatin chemotherapy. Participants are adults with gastrointestinal solid tumors who stopped oxaliplatin-based treatment and still…
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC